Silencing of phosphonate-gadolinium magnetic resonance imaging contrast by hydroxyapatite binding.
Alves FC, Donato P, Sherry AD, Zaheer A, Zhang S, Lubag AJ, Merritt ME, Lenkinski RE, Frangioni JV, Neves M, Prata MI, Santos AC, de Lima JJ, Geraldes CF. Silencing of phosphonate-gadolinium magnetic resonance imaging contrast by hydroxyapatite binding. Invest Radiol. 2003 Dec; 38(12):750-60.